PT874621E - Composicoes farmaceuticas - Google Patents

Composicoes farmaceuticas

Info

Publication number: PT874621E
Authority: PT; Portugal
Prior art keywords: phosphatidylglycerol; sub; salt; active agent; stabiliser
Prior art date: 1996-01-19

Application number

PT97901563T

Other languages

English (en)

Inventor

Harry Tiemessen

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-19

Filing date

1997-01-20

Publication date

2003-09-30

1997-01-20 Application filed by Novartis Ag filed Critical Novartis Ag

2003-09-30 Publication of PT874621E publication Critical patent/PT874621E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Immunology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Diabetes (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Dispersion Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Neurosurgery (AREA)
Transplantation (AREA)

PT97901563T 1996-01-19 1997-01-20 Composicoes farmaceuticas PT874621E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9601120.0A GB9601120D0 (en)	1996-01-19	1996-01-19	Organic compounds

Publications (1)

Publication Number	Publication Date
PT874621E true PT874621E (pt)	2003-09-30

Family

ID=10787276

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT97901563T PT874621E (pt)	1996-01-19	1997-01-20	Composicoes farmaceuticas
PT05018663T PT1679064E (pt)	1996-01-19	1997-01-20	Composições farmacêuticas contendo derivados de rapamicina

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT05018663T PT1679064E (pt)	1996-01-19	1997-01-20	Composições farmacêuticas contendo derivados de rapamicina

Country Status (14)

Country	Link
US (2)	USRE42014E1 (pt)
EP (4)	EP0874621B1 (pt)
JP (2)	JP4077386B2 (pt)
KR (1)	KR100485146B1 (pt)
AT (4)	ATE510532T1 (pt)
AU (1)	AU1543497A (pt)
CA (2)	CA2678707A1 (pt)
DE (3)	DE69734253T2 (pt)
DK (4)	DK1273288T3 (pt)
ES (4)	ES2247245T3 (pt)
GB (1)	GB9601120D0 (pt)
HK (3)	HK1054183B (pt)
PT (2)	PT874621E (pt)
WO (1)	WO1997025977A1 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5660858A (en) *	1996-04-03	1997-08-26	Research Triangle Pharmaceuticals	Cyclosporin emulsions
PT1208847E (pt)	1996-07-30	2007-07-24	Novartis Ag	Composições farmacêuticas para o tratamento da rejeição de transplantes, doenças autoimunes ou inflamatórias compreendendo ciclosporina a e 40-0-(2-hidroxietil)-rapamicina
US20030199425A1 (en) *	1997-06-27	2003-10-23	Desai Neil P.	Compositions and methods for treatment of hyperplasia
DE69842121D1 (de)	1997-12-10	2011-03-17	Cyclosporine Therapeutics Ltd	Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
DE19810655A1 (de) *	1998-03-12	1999-09-16	Univ Eberhard Karls	Arzneimittel mit einem Gehalt an Ciclosporin
AR018376A1 (es)	1998-05-26	2001-11-14	Novartis Ag	Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento
US6376517B1 (en) *	1998-08-14	2002-04-23	Gpi Nil Holdings, Inc.	Pipecolic acid derivatives for vision and memory disorders
US7265150B1 (en) *	1998-08-14	2007-09-04	Gpi Nil Holdings Inc.	Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders
BR0011225A (pt) *	1999-04-30	2002-03-19	Sucampo Ag	Agente para tratar de olhos secos, seu método e uso
US7063857B1 (en)	1999-04-30	2006-06-20	Sucampo Ag	Use of macrolide compounds for the treatment of dry eye
DE60044717D1 (de)	1999-05-10	2010-09-02	Paolo Brenner	Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
US6720001B2 (en) *	1999-10-18	2004-04-13	Lipocine, Inc.	Emulsion compositions for polyfunctional active ingredients
ES2256305T3 (es)	2000-10-31	2006-07-16	Pharma Mar, S.A.	Formulaciones de kahalalide f.
DK3342411T3 (da)	2001-02-19	2019-09-02	Novartis Pharma Ag	Rapamycinderivat til behandling af pancreascancer
AU2002320407A1 (en) *	2001-07-10	2003-01-29	Trustees Of Boston University	Modified-fat nutritional products useful for preventing or treating obesity
US20040137066A1 (en) *	2001-11-26	2004-07-15	Swaminathan Jayaraman	Rationally designed therapeutic intravascular implant coating
US6641611B2 (en)	2001-11-26	2003-11-04	Swaminathan Jayaraman	Therapeutic coating for an intravascular implant
CA2461740C (en)	2001-10-19	2013-02-12	Isotechnika Inc.	Synthesis of cyclosporin analogs
JP2006522007A (ja) *	2002-11-15	2006-09-28	ノバルティスアクチエンゲゼルシャフト	ドラッグ・デリバリー・システム
GB0307867D0 (en) *	2003-04-04	2003-05-14	Novartis Ag	Pharmaceutical composition
GB0307866D0 (en) *	2003-04-04	2003-05-14	Novartis Ag	Pharmaceutical composition
WO2005027906A1 (en) *	2003-09-18	2005-03-31	Macusight, Inc.	Transscleral delivery
US20080311207A1 (en) *	2004-09-08	2008-12-18	Manoj Varshney	Micelles and Nanoemulsions for Preventive and Reactive Treatment of Atherosclerosis
GB0428151D0 (en)	2004-12-22	2005-01-26	Novartis Ag	Organic compounds
US8663639B2 (en) *	2005-02-09	2014-03-04	Santen Pharmaceutical Co., Ltd.	Formulations for treating ocular diseases and conditions
GB2438544A (en)	2005-02-09	2007-11-28	Cooper Internat Corp	Liquid formulations for treatment of diseases or conditions
CN101605529B (zh)	2006-02-09	2013-03-13	参天制药株式会社	稳定制剂及它们的制备和使用方法
PL2001466T3 (pl)	2006-03-23	2016-06-30	Santen Pharmaceutical Co Ltd	Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
US7883855B2 (en)	2006-07-21	2011-02-08	Abbott Laboratories	Immunosuppressant drug extraction reagent for immunoassays
EP2086602A2 (en) *	2006-11-20	2009-08-12	Lutonix, Inc.	Drug releasing coatings for medical devices
US20080175887A1 (en) *	2006-11-20	2008-07-24	Lixiao Wang	Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
CA2673296C (en)	2006-12-29	2012-10-16	Abbott Laboratories	Improved assay for immunosuppressant drugs
CA2672972C (en)	2006-12-29	2015-06-23	Abbott Laboratories	Diagnostic test for the detection of a molecule or drug in whole blood
US7914999B2 (en) *	2006-12-29	2011-03-29	Abbott Laboratories	Non-denaturing lysis reagent
EP2118657B1 (en)	2006-12-29	2014-05-21	Abbott Laboratories	Non-denaturing lysis reagent for use with capture-in-solution immunoassay
FR2911069B1 (fr) *	2007-01-09	2009-04-03	Physica Pharma Soc Par Actions	Composition pharmaceutique parenterale et son procede de preparation
US20080265343A1 (en) *	2007-04-26	2008-10-30	International Business Machines Corporation	Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
CN102202672A (zh) *	2008-10-10	2011-09-28	达拉生物科学公司	使用穗霉素衍生物治疗或预防疼痛的方法
EP2682106A1 (en)	2012-07-03	2014-01-08	Phares Pharmaceutical Research N.V.	Method of solubilizing biologically active compounds
AU2014209141B2 (en)	2013-01-24	2018-05-10	Palvella Therapeutics, Inc.	Compositions for transdermal delivery of mTOR inhibitors
HUP1400075A2 (hu)	2014-02-14	2015-08-28	Druggability Technologies Ip Holdco Jersey Ltd	Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói
MY194730A (en)	2016-10-28	2022-12-15	Novartis Ag	Liposomal Formulation for use in the Treatment of Cancer
IL267869B2 (en)	2017-01-06	2023-10-01	Palvella Therapeutics Inc	Non-aqueous preparations of mTOR inhibitors and methods of use
WO2020010073A1 (en)	2018-07-02	2020-01-09	Palvella Therapeutics, Inc.	ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
KR102003183B1 (ko)	2019-02-27	2019-07-24	배영진	안면마스크

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE296122C (pt) *
US4707470A (en)	1985-05-17	1987-11-17	Smithkline Beckman Corporation	Polyene antibiotic emulsion formulation
CA1323306C (en)	1987-03-05	1993-10-19	Mircea C. Popescu	Pharmacological agent-lipid solution preparation
ATE95193T1 (de)	1987-06-17	1993-10-15	Sandoz Ag	Cyclosporine und deren benutzung als arzneimittel.
JP2688235B2 (ja)	1987-09-07	1997-12-08	帝人株式会社	医薬物質含有脂肪乳剤の用時調製型キットおよび医薬物質含有脂肪乳剤の調製方法
IL88076A (en)	1987-10-28	1993-01-14	Nippon Shinyaku Co Ltd	Fat emulsions as drug carriers
AU598958B2 (en)	1987-11-12	1990-07-05	Vestar, Inc.	Improved amphotericin b liposome preparation
EP0356399A3 (en) *	1988-08-26	1991-03-20	Sandoz Ag	Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them
KR0148748B1 (ko) *	1988-09-16	1998-08-17	장 크라메르, 한스 루돌프 하우스	사이클로스포린을 함유하는 약학조성물
DD295766A5 (de) *	1988-10-10	1991-11-14	Arzneimittelwerk Dresden Gmbh,De	Verfahren zur herstellung galenischer arzneiformen von ciclosporinen
JP2502719B2 (ja)	1988-12-28	1996-05-29	集合住宅用新材料・機器システム開発技術研究組合	冷暖給湯ヒ―トポンプシステム
DE69016515T2 (de)	1989-07-05	1995-06-08	Fujisawa Pharmaceutical Co	Wässriges flüssiges Mittel zur äusserlichen Anwendung.
JPH03147892A (ja)	1989-11-06	1991-06-24	Mitsubishi Rayon Co Ltd	昇華性分散染料易染性樹脂組成物
US5352671A (en) *	1989-11-09	1994-10-04	Sandoz Ltd.	Heteroatoms-containing tricyclic compounds
NZ235991A (en) *	1989-11-09	1993-05-26	Sandoz Ltd	Macrolide compounds and pharmaceutical compositions thereof
JPH04253907A (ja) *	1990-05-23	1992-09-09	Green Cross Corp:The	静脈注射用免疫抑制剤
IE65341B1 (en)	1990-11-08	1995-10-18	Fujisawa Pharmaceutical Co	Suspensions containing tricyclic compounds
MX9201782A (es)	1991-04-19	1992-10-01	Sandoz Ag	Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
IL102414A (en)	1991-07-25	1996-08-04	Univ Louisville Res Found	Medicinal preparations for the treatment of ocular inflammation, containing rapamycin
US5457111A (en) *	1991-09-05	1995-10-10	Abbott Laboratories	Macrocyclic immunomodulators
KR100253492B1 (ko)	1991-10-31	2000-05-01	후지야마 아키라	트리사이클로화합물함유 리포솜제제(liposome preparation containing tricyclic compound)
GB9208712D0 (en) *	1992-04-22	1992-06-10	Sandoz Ltd	Pharmaceutical compositions containing cyclosporin derivates
DE59310166D1 (de)	1992-05-18	2001-05-31	Ciclomulsion Ag	Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur intravenösen Applikation sowie Verfahren zu ihrer Herstellung
EP1142568A1 (en) *	1992-09-25	2001-10-10	Novartis AG	Pharmaceutical compositions containing cyclosporins
GB9221220D0 (en) *	1992-10-09	1992-11-25	Sandoz Ag	Organic componds
JPH06183970A (ja) *	1992-12-16	1994-07-05	Fujisawa Pharmaceut Co Ltd	医薬用組成物
CH686761A5 (de)	1993-05-27	1996-06-28	Sandoz Ag	Galenische Formulierungen.
GB2278780B (en) *	1993-05-27	1998-10-14	Sandoz Ltd	Macrolide formulations
AU688782B2 (en) *	1993-09-30	1998-03-19	Wyeth	Rapamycin formulations for oral administration
FI100692B (fi) *	1994-05-24	1998-02-13	Leiras Oy	Menetelmä farmaseuttisten koostumusten valmistamiseksi, jolloin koostu mukset pohjautuvat mikroemulsiogeeleihin sekä uusia mikroemulsioihin p ohjautuvia geelejä
DK0786986T3 (da) *	1994-10-26	2002-04-29	Novartis Ag	Anvendelse af en umættet fedtalkohol

1996
- 1996-01-19 GB GBGB9601120.0A patent/GB9601120D0/en active Pending
1997
- 1997-01-20 CA CA002678707A patent/CA2678707A1/en not_active Abandoned
- 1997-01-20 AT AT05018663T patent/ATE510532T1/de active
- 1997-01-20 EP EP97901563A patent/EP0874621B1/en not_active Expired - Lifetime
- 1997-01-20 US US10/345,665 patent/USRE42014E1/en not_active Expired - Lifetime
- 1997-01-20 ES ES02022256T patent/ES2247245T3/es not_active Expired - Lifetime
- 1997-01-20 EP EP02022256A patent/EP1273288B1/en not_active Expired - Lifetime
- 1997-01-20 WO PCT/EP1997/000252 patent/WO1997025977A1/en active IP Right Grant
- 1997-01-20 AT AT97901563T patent/ATE239449T1/de active
- 1997-01-20 AT AT02022256T patent/ATE304842T1/de active
- 1997-01-20 DE DE69734253T patent/DE69734253T2/de not_active Expired - Lifetime
- 1997-01-20 DK DK02022256T patent/DK1273288T3/da active
- 1997-01-20 ES ES05018663T patent/ES2365734T3/es not_active Expired - Lifetime
- 1997-01-20 US US09/091,072 patent/US6239102B1/en not_active Ceased
- 1997-01-20 DK DK05018663.4T patent/DK1679064T3/da active
- 1997-01-20 ES ES02022257T patent/ES2253483T3/es not_active Expired - Lifetime
- 1997-01-20 PT PT97901563T patent/PT874621E/pt unknown
- 1997-01-20 PT PT05018663T patent/PT1679064E/pt unknown
- 1997-01-20 EP EP02022257A patent/EP1273289B1/en not_active Expired - Lifetime
- 1997-01-20 EP EP05018663A patent/EP1679064B1/en not_active Expired - Lifetime
- 1997-01-20 DE DE69721729T patent/DE69721729T2/de not_active Expired - Lifetime
- 1997-01-20 AU AU15434/97A patent/AU1543497A/en not_active Abandoned
- 1997-01-20 AT AT02022257T patent/ATE310504T1/de active
- 1997-01-20 DK DK02022257T patent/DK1273289T3/da active
- 1997-01-20 KR KR10-1998-0704696A patent/KR100485146B1/ko not_active IP Right Cessation
- 1997-01-20 CA CA2240339A patent/CA2240339C/en not_active Expired - Lifetime
- 1997-01-20 DE DE69734742T patent/DE69734742T2/de not_active Expired - Lifetime
- 1997-01-20 ES ES97901563T patent/ES2199338T3/es not_active Expired - Lifetime
- 1997-01-20 DK DK97901563T patent/DK0874621T3/da active
1999
- 1999-02-05 HK HK03104827.8A patent/HK1054183B/zh not_active IP Right Cessation
- 1999-02-05 HK HK99100514A patent/HK1015277A1/xx not_active IP Right Cessation
- 1999-02-05 HK HK03104828.7A patent/HK1053973B/zh not_active IP Right Cessation
2003
- 2003-09-29 JP JP2003337458A patent/JP4077386B2/ja not_active Expired - Lifetime
2007
- 2007-06-19 JP JP2007161630A patent/JP2007246543A/ja active Pending

Also Published As

Publication number	Publication date
HK1053973B (zh)	2006-09-29
EP0874621B1 (en)	2003-05-07
USRE42014E1 (en)	2010-12-28
CA2240339C (en)	2010-11-16
HK1053973A1 (en)	2003-11-14
CA2678707A1 (en)	1997-07-24
ATE304842T1 (de)	2005-10-15
DE69734253T2 (de)	2006-07-06
EP0874621A1 (en)	1998-11-04
ATE310504T1 (de)	2005-12-15
ES2253483T3 (es)	2006-06-01
HK1054183B (zh)	2006-07-28
JP2004107350A (ja)	2004-04-08
EP1273289B1 (en)	2005-11-23
EP1679064A2 (en)	2006-07-12
DE69734253D1 (de)	2006-02-02
AU1543497A (en)	1997-08-11
DK1273289T3 (da)	2006-03-20
ATE510532T1 (de)	2011-06-15
DE69721729D1 (de)	2003-06-12
EP1273289A1 (en)	2003-01-08
PT1679064E (pt)	2011-07-25
DK1679064T3 (da)	2011-09-12
DE69721729T2 (de)	2003-12-11
GB9601120D0 (en)	1996-03-20
US6239102B1 (en)	2001-05-29
DK1273288T3 (da)	2005-11-21
ES2365734T3 (es)	2011-10-10
KR19990076603A (ko)	1999-10-15
EP1273288B1 (en)	2005-09-21
JP4077386B2 (ja)	2008-04-16
ES2199338T3 (es)	2004-02-16
HK1054183A1 (en)	2003-11-21
JP2000503655A (ja)	2000-03-28
CA2240339A1 (en)	1997-07-24
EP1679064B1 (en)	2011-05-25
DE69734742D1 (de)	2005-12-29
DE69734742T2 (de)	2006-07-27
ATE239449T1 (de)	2003-05-15
HK1015277A1 (en)	1999-10-15
WO1997025977A1 (en)	1997-07-24
DK0874621T3 (da)	2003-09-01
EP1679064A3 (en)	2009-10-07
EP1273288A1 (en)	2003-01-08
JP3763581B2 (ja)	2006-04-05
JP2007246543A (ja)	2007-09-27
KR100485146B1 (ko)	2005-10-12
ES2247245T3 (es)	2006-03-01

Publication	Publication Date	Title
PT874621E (pt)	2003-09-30	Composicoes farmaceuticas
US5059593A (en)	1991-10-22	Pour-on formulations which are active against ticks
NO20005431D0 (no)	2000-10-27	Gelérbare farmasøytiske preparater
KR970706021A (ko)	1997-11-03	N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
BE900345A (fr)	1984-12-03	Composition pharmaceutique ophtalmiques a base d'un derive d'acide phenylacetique.
DK0525307T3 (da)	1996-04-01	Stabile præparater til parenteral indgivelse og deres anvendelse
US4594357A (en)	1986-06-10	Depot antiinflammatory agents
JPH0113681B2 (pt)	1989-03-07
RU97118134A (ru)	1999-07-10	Новые противовирусные гомокарбоциклические нуклеозидные производные замещенных пиримидиндионов, способы их получения и композиции, содержащие их в качестве активных ингредиентов
KR930703251A (ko)	1993-11-29	에어로졸 제제
RU95107147A (ru)	1997-03-20	Производные циклогексанкарбоновой кислоты, смесь их изомеров или отдельные изомеры и физиологически переносимые соли и фармацевтическая композиция с тормозящей ферментный комплекс глюкоза-6-фосфатазы печени активностью
SU1573021A1 (ru)	1990-06-23	14 @ -Окси-7,8-метилендиоксиаллобербан, обладающий антидепрессивной активностью
US5034420A (en)	1991-07-23	Compositions and method for stabilization of anthralin comprising the addition of an oil soluble antioxidant and an anionic surfactant
JPS62127B2 (pt)	1987-01-06
GB2142534A (en)	1985-01-23	Stabilization of compositions with anionic surfactant
ATE23150T1 (de)	1986-11-15	Aminoethoxybenzylalkohol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR940003459A (ko)	1994-03-12	바퀴를 박멸하는 방법 및 제제
KR880013874A (ko)	1988-12-22	카르복실산 에스테르, 그의 제조방법 및 그것을 유효 성분으로 함유하는 살충제
KR830006178A (ko)	1983-09-20	부작용감소와 약효시간이 연장된 새로운 기관지 진정제의 제조방법
YU45994A (sh)	1997-12-05	Farmaceutski preparati za prevenciju i/ili tretiranje gastrointenstinalnih oboljenja uključujući ulkus